Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |